Alden Maier, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Raleigh, NCNPI 1083834212
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,521 of the $20,301 with a category attached, or 66.6%. Edwards Lifesciences accounts for 89.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $18,539 and has fallen 97.9% since, to $397 in 2025.
Across 35 payments — averaging $580.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$18K
- Intuitive Surgical$2K
- Davol Inc.$209
- Kerecis Limited$150
- Veran Medical Technologies, Inc.$132
- Bard Peripheral Vascular, Inc.$23
- plus $42 from 2 others
What the payments were for
- Consulting fees$13,52167%
- Travel & lodging$4,98225%
- Food & beverage$1,7779%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 14 | $18,240 |
| Intuitive Surgical | 11 | $1,505 |
| Davol Inc. | 4 | $209 |
| Kerecis Limited | 1 | $150 |
| Veran Medical Technologies, Inc. | 2 | $132 |
| Bard Peripheral Vascular, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Covidien LP | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,301 in reported general payments places this provider in the 75th percentile of 132 thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina.
See all thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 17 | $151 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Raleigh
- Joseph RubelowskyRaleigh$2.2M
- Charles HarrRaleigh$90K
- Robert PeytonRaleigh$84K
- Judson WilliamsRaleigh$56K
- Bryon BoultonRaleigh$40K
- Clifton ReadeRaleigh$16K
- Curtis AndersonRaleigh$9K
- Matthew HartwigDurham$406K
- Gregory SmaroffNew Bern$205K
- David HarpoleDurham$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.